Since the onset of the coronavirus disease 2019 (COVID-19), numerous neutralizing
antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The potential for future coronavirus outbreaks highlights the need to broadly target this
group of pathogens. We used an epitope-agnostic approach to identify six monoclonal …

The brutal toll of another viral pandemic can be blunted by investing now in research that
uncovers mechanisms of broad-based immunity so we may have vaccines and therapeutics …

The current study was initiated when our specific-pathogen-free laboratory toms developed
unexpectedly high levels of cross-reactive antibodies to human SARS-CoV-2 (SCoV2) …

The continuous emergence of new variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) urges better understanding of the functional motifs in the spike …

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has devastated public health and the …

Abstract The coronavirus disease 2019 (COVID-19) pandemic recently demonstrated the
devastating impact on public health, economy, and social development of zoonotic …

Despite the vaccination campaigns for COVID-19, we still cannot control the spread of SARS-
CoV-2, as evidenced by the ongoing circulation of the Omicron variants of concern. This …

Currently circulating SARS-CoV-2 variants have gained complete or significant resistance to
all SARS-CoV-2-neutralizing antibodies that have been used in the clinic. Such antibodies …

Feline infectious peritonitis (FIP) is a lethal disease caused by a pathogenic coronavirus,
feline infectious peritonitis virus (FIPV), in cats. Effective vaccines have been unsuccessful …